Insider · CIK 0002009713
Wein Matthew
Reports to the SEC for 1 company · EMERYVILLE, CA
Transactions
16
Companies
1
Filings
10
CIK
0002009713
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-08 | MGXMetagenomi Therapeutics, Inc.S Sale | −$414.707 |
| 2026-06-05 | MGXMetagenomi Therapeutics, Inc.S Sale | −$724.842 |
| 2026-04-01 | MGXMetagenomi Therapeutics, Inc.A Award | — |
| 2026-04-01 | MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-03-05 | MGXMetagenomi Therapeutics, Inc.S Sale | −$771.2 |
| 2025-12-05 | MGXMetagenomi Therapeutics, Inc.S Sale | −$352.608 |
| 2025-12-01 | MGXMetagenomi Therapeutics, Inc.A Award | +$154K |
| 2025-09-05 | MGXMetagenomi Therapeutics, Inc.S Sale | −$360.19 |
| 2025-06-06 | MGXMetagenomi Therapeutics, Inc.S Sale | −$348.25 |
| 2025-04-01 | MGXMetagenomi Therapeutics, Inc.A Award | — |
| 2025-04-01 | MGXMetagenomi Therapeutics, Inc.A Award | — |
| 2025-04-01 | MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-04-01 | MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-03-05 | MGXMetagenomi Therapeutics, Inc.S Sale | −$1,743.564 |
| 2024-04-01 | MGXMetagenomi Therapeutics, Inc.A Award | — |
| 2024-04-01 | MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Wein Matthew0001193125-26-387816SEC(opens sec.gov)
- 4Wein Matthew0001193125-26-265326SEC(opens sec.gov)
- 4Wein Matthew0001193125-26-141914SEC(opens sec.gov)
- 4Wein Matthew0001193125-26-098821SEC(opens sec.gov)
- 4Wein Matthew0001193125-25-310958SEC(opens sec.gov)
- 4Wein Matthew0001193125-25-304177SEC(opens sec.gov)
- 4Wein Matthew0000950170-25-083963SEC(opens sec.gov)
- 4Wein Matthew0000950170-25-050100SEC(opens sec.gov)
- 4Wein Matthew0000950170-25-035566SEC(opens sec.gov)
- 4Wein Matthew0000950170-24-041545SEC(opens sec.gov)
Companies
Address
C/O METAGENOMI THERAPEUTICS, INC. 5959 HORTON STREET, 7TH FLOOR
EMERYVILLE, CA, 94608